Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

August 23, 2024
Selecting and Sequencing Therapy for Patients with DLBCL in an Era of Expanding Options The Community Oncology Connections™ Program will feature didactic presentations coupled with cases and discussion. This provides an ideal format to exchange ideas and viewpoints, as well as to hear experts apply the latest practice-changing clinical trial data, evidence-based testing, and therapeutic strategies …
August 22, 2024
You’re invited to participate in the Targeted Oncology™ and Oncology Nursing News® Community Case Forum™ on Thursday, August 22 at The Westin St. Louis in St. Louis, Missouri. HRA® offers compensation of $750 to medical oncologists/hematologists and $500 to advanced practice providers for their consultative insights. After arriving, you’ll spend some time networking with peers while enjoying small …
August 21, 2024
You’re invited to participate in the Targeted Oncology™ Community Case Forum™ on Wednesday, August 21 at Grand Bohemian Hotel Charlotte, Autograph Collection. HRA® offers compensation of $750 to medical oncologists/hematologists for their consultative insights. With prior approval from our registration team, a small number of fellows and advanced practice providers may be eligible to attend. After …
August 21, 2024
Join us for the next HSCO symposium in the 2024 series! Enjoy a complimentary evening of dining, networking with oncology professionals, and gaining insights into the latest HR+ breast cancer treatment paradigms. Don’t miss this exclusive opportunity to learn from Dr. Seth Wander, MD, PhD. Reserve your complimentary spot today! PROVIDER REGISTRATIONVIEW AGENDA Provider Registration - inclusive of licensed …
August 20, 2024
As of January 1, 2024, the Centers for Medicare and Medicaid Services introduced new codes so that Medicare could reimburse for patient navigation services, addressing a long-standing need. In order to guide implementation the Association of Cancer Care Centers will be holding a 4-part webinar series, Implementing the New CMS Reimbursement Billing Codes for Patient Navigation Services. This webinar …
Virtual Program Schedule Making Small Cell Lung Cancer Not So Small Anymore: A REVIEW OF EPIDEMIOLOGY, TREATMENT LANDSCAPE, AND LONG-TERM MANAGEMENT Tuesday, September 17, 2024 Wednesday, September 18, 2024 Thursday, September 19, 2024 Mark Socinski, MD Attending Physician Executive Medical Director AdventHealth Cancer Institute Orlando, Florida Frank Weinberg, MD, PhD Assistant …
This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. TACOS ONCOLOGY DRUG NEWSLETTER A U G U S T 2 0 2 4 FDA APPROVALS Tepylute (SH-105) The FDA has approved Tepylute (SH-105), a ready- to-dilute formulation of an existing treatment for breast and ovarian adenocarcinoma.1 The original …
SOCIAL DRIVERS OF HEALTH PROVIDER SURVEY RESULTS: A FOCUS ON METASTATIC BREAST CANCER 1 BACKGROUND AND OVERVIEW Social drivers of health (SDOH) are individual factors that directly or indirectly influence a person’s health outcomes. Research shows that SDOH factors, including access to quality nutrition, stable housing, basic utilities, transportation, and an environment free from …
BMT and Rehab CAR-T and Rehab Comprehensive Care of the Bone Marrow Transplant Patient Macy Hogan, PT, DPT Franciscan Health Objectives • To address special considerations for BMT patients to improve awareness, clinical reasoning, and standard of care when treating a BMT patient, particularly patients undergoing CAR-T therapy • To improve awareness of changes in …
PowerPoint Presentation Perspectives from CAR T Treaters and Referrers in an Evolving B-Cell Lymphoma Landscape Girish Kunapareddy, MD Hematologist/Oncologist Union Health Rita Assi, MD Assistant Professor of Medicine Indiana University Melvin and Bren Simon Comprehensive Cancer Center Daniel Wojenski, PharmD Medical Science Liaison, Cell Therapy Bristol Myers …
PowerPoint Presentation ASCO State of the Union Indiana Oncology Society Robin Zon, MD, FACP, FASCO ASCO President August 16, 2024 Disclosure Information Relationships with Companies Zon, Robin Stock or Other Ownership Interests: AC3 - a Healthcare Technology Company, ARK Genomic Revolution, AstraZeneca, Athenex, Berkshire Hathaway, Crispr, Cytosorbents, iShafes …
CAR-T Navigation Emily Ebelhar, BSN, RN Bone Marrow Transplant and Immune Cell Therapy Nurse Coordinator IU Health Objectives • What is a Navigator? • Real life patient cases o Navigating unique social situations o Going beyond the normal standards • Questions What is a Navigator? Let's Meet Our First Patient John Jones • 77-year-old, Male • Stage …
PowerPoint Presentation Introduction to CAR T-Cell Therapy Michael Dugan,MD Consultant Indiana Blood and Marrow Transplantation Disclosures Relevant to today’s presentation Speaker honoraria and consultancy: Bristol Myers Squibb including CAR T therapies Relevant to today’s presentation Consultancy: Point of Care Partners regarding CAR T therapies …
PowerPoint Presentation Prior Authorization & the Impact of Utilization Management Practices Maxine Miller Coordinator, Policy & Advocacy Cancer Support Community Cancer Support Community Largest professionally led nonprofit network of cancer support worldwide Mission to uplift and strengthen people impacted by cancer by providing support, fostering compassionate …
August 17, 2024
You are invited to attend the upcoming Advances in Oncology and Hematology event hosted by The Department of Medicine, Divisions of Hematology & Oncology at the Washington University School of Medicine in St. Louis. The course will provide an overview of the recent advances in the diagnosis and treatment of a wide variety of solid tumors and hematologic malignancies. The case-based discussions …
August 16, 2024
Discover the future of cancer care at the Indiana Oncology Society (IOS) 2024 Oncology Practice Summit, where you'll gain insights into the latest advancements in oncology. Immerse yourself in captivating sessions, including a state of the union address from the newly elected ASCO President. Explore critical topics such as financials, rehab, and navigators in CAR T, as well as perspectives from CAR …
This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. NCOA ONCOLOGY DRUG NEWSLETTER A U G U S T 2 0 2 4 FDA APPROVALS Tepylute (SH-105) The FDA has approved Tepylute (SH-105), a ready- to-dilute formulation of an existing treatment for breast and ovarian adenocarcinoma.1 The original …
August 16, 2024
Reunite with the John A. Burns School of Medicine (JABSOM) alumni at the 2024 JABSOM Alumni Association All Class Reunion & Educational Symposium! This event, taking place at the Hyatt Maui Regency Resort from August 16th to 18th, offers a valuable opportunity to expand your professional network, learn from oncology experts, and build lasting relationships. Click below for more details and to register …
Novel cancer therapies have emerged over the past 10-15 years with high rates of cutaneous side effects, leading to increased demand for specialists in oncodermatology. These subspecialists have expertise in managing therapeutic complications, cutaneous metastases, and proactive management of potential adverse events. In this episode, CANCER BUZZ TV speaks with guest Meghan Heberton, MD, director …
IOS-IA 2024 Best of ASCO Saturday August 24, 2024 The Graduate Iowa City, IA Attendee Roster First Name Last Name Title Account Name Javier Leaniz TLL Abbvie Scott Vance Oncology Account Executive Abbvie Dulabh Monga Medical Oncologist Allegheny Health Network Jason Cohen Sr. Manager MSL Astellas Dena McDowell Account Specialist Astellas Jimmy Gilbreath Oncology …